Skip to main content
Clinical Trials/NCT04379349
NCT04379349
Completed
N/A

Using Short Message Service as a Means of Clinical Engagement in Early Psychosis

Centre for Addiction and Mental Health1 site in 1 country61 target enrollmentJanuary 1, 2018

Overview

Phase
N/A
Intervention
Not specified
Conditions
Psychotic Disorders
Sponsor
Centre for Addiction and Mental Health
Enrollment
61
Locations
1
Primary Endpoint
Service Engagement Scale (SES)
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

Engagement with clinical services for youth with early psychosis represents a significant challenge, with up to 40% of patients dropping out of treatment in the first year. This has been linked to worse illness outcomes and represents a significant barrier to recovery for these patients. This study aims to evaluate the efficacy of short message service (SMS) as a means of improving clinical engagement in early-episode psychosis populations by bridging contact between appointments with weekly check-ins/reminders. These weekly check-ins during the first year of treatment will serve as an additional opportunity to reach out to patients and give them a chance to do the same with their care teams, with patient responses triggering clinician follow-up if necessary.

Registry
clinicaltrials.gov
Start Date
January 1, 2018
End Date
March 31, 2020
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

George Foussias

Clinician Scientist

Centre for Addiction and Mental Health

Eligibility Criteria

Inclusion Criteria

  • between the ages of 16-29
  • a diagnosis of an affective or non-affective psychotic disorder (i.e., Bipolar or Major Depressive Disorders with Psychotic Features, Schizophrenia Spectrum Disorders, Other Specified Psychotic Disorders, Substance Induced Psychosis and Attenuated Psychotic Syndrome)
  • eligible for follow-up within the Slaight Family Centre for Youth in Transition early intervention service
  • within the first 6 months of treatment

Exclusion Criteria

  • involved in another intervention study
  • do not have a personal cell phone number

Outcomes

Primary Outcomes

Service Engagement Scale (SES)

Time Frame: 9 months

Clinician-rated treatment engagement and adherence (minimum score = 0, maximum score = 42, higher score indicates worse service engagement)

Appointment Attendance

Time Frame: 9 months

Percentage of attended clinic appointments

Secondary Outcomes

  • Emergency Department Visits(9 months)
  • Hospitalizations(9 months)
  • Social Functioning Scale (SFS)(9 months)
  • Clinical Global Impression (CGI)(9 months)
  • Personal and Social Performance Scale (PSP)(9 months)
  • Quality of Life Enjoyment and Satisfaction Questionnaire (Q-LESQ-18)(9 months)
  • Scale for the Assessment of Negative Symptoms (SANS)(9 months)
  • Drug Attitude Inventory (DAI-10)(9 months)
  • Brief Psychiatric Rating Scale (BPRS)(9 months)
  • Apathy Evaluation Scale (AES)(9 months)
  • Scale To Assess Therapeutic Relationships - Patient Version (STAR-P)(9 months)
  • Brief Cognitive Assessment Tool for Schizophrenia (B-CATS)(9 months)

Study Sites (1)

Loading locations...

Similar Trials